# melanoma (audio feeds) — RSS Amplifier Recent posts from the 2 feeds in the RSS Amplifier directory that cover melanoma. Page: Feed: --- ## [From collaboration to innovation: How multidisciplinary teams and clinical trials are transforming melanoma care](https://podcasters.spotify.com/pod/show/melanoma-insights/episodes/From-collaboration-to-innovation-How-multidisciplinary-teams-and-clinical-trials-are-transforming-melanoma-care-e3m6je4) _2026-07-17 · Melanoma Institute Australia · Melanoma Insights for Professionals_ In this episode from MIA’s podcast Melanoma Insights for Professionals , our experts explore the critical role of multidisciplinary collaboration in delivering contemporary melanoma care. Hear how melanoma multidisciplinary teams (MDTs) bring together diverse expertise to navigate increasingly complex treatment pathways, discuss challenging cases and identify opportunities for patients to… [Listen](https://anchor.fm/s/a3c9a830/podcast/play/122948484/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-6-17%2F428112875-44100-2-c05a4922943e7.m4a) ## [Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit](https://dermatologic.researchtopractice.com/episode/6009-gmo26-desmoid) _2026-06-27 · Dermatologic Oncology Update_ Featuring perspectives from Dr Mrinal Gounder and Dr Richard F Riedel, including the following topics: Introduction (0:00) Desmoid Tumors — Dr Gounder (2:58) Soft Tissue Sarcoma — Dr Riedel (28:29) CME information and select publications [Listen](https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/26b20c17-3183-4039-9cbe-1b6cdd3923c9.mp3) ## [Redefining Immunotherapy (Ep. 5): Hype vs Reality: The Future of Immunotherapy](https://podcasters.spotify.com/pod/show/melanoma-insights/episodes/Redefining-Immunotherapy-Ep--5-Hype-vs-Reality-The-Future-of-Immunotherapy-e3k0ls7) _2026-06-07 · Melanoma Institute Australia · Melanoma Insights for Professionals_ In our final episode of our special vodcast series, Redefining Immunotherapy: Lessons from Melanoma , our experts discuss the future of immunotherapy, separating hype from reality and exploring the next frontier of cancer treatment. From cellular therapies and personalised cancer vaccines to mRNA technology and biomarker-driven treatment selection, the panel examines the innovations that could… [Listen](https://anchor.fm/s/a3c9a830/podcast/play/120657223/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-28%2F425044939-44100-2-23cfc82f6fe16.mp3) ## [Redefining Immunotherapy (Ep. 4): Melanoma Treatment Strategy: Expert Perspectives](https://podcasters.spotify.com/pod/show/melanoma-insights/episodes/Redefining-Immunotherapy-Ep--4-Melanoma-Treatment-Strategy-Expert-Perspectives-e3jkl1h) _2026-05-31 · Melanoma Institute Australia · Melanoma Insights for Professionals_ In our fourth episode of our special vodcast series, Redefining Immunotherapy: Lessons from Melanoma , our experts discuss one of the most rapidly evolving areas in melanoma care: immunotherapy treatment strategy. Drawing on decades of combined clinical experience, the panel explores how treatment paradigms are shifting from decisions around monotherapy versus combination immunotherapy, to… [Listen](https://anchor.fm/s/a3c9a830/podcast/play/120263153/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-20%2F424519733-44100-2-e3d821286b9b4.mp3) ## [\[Trailer\] Redefining Immunotherapy (Ep. 4): Melanoma Treatment Strategy](https://podcasters.spotify.com/pod/show/melanoma-insights/episodes/Trailer-Redefining-Immunotherapy-Ep--4-Melanoma-Treatment-Strategy-e3k0kut) _2026-05-28 · Melanoma Institute Australia · Melanoma Insights for Professionals_ Here's a sneak peak for our upcoming episode of Redefining Immunotherapy: Lessons from Melanoma. In this episode, our experts discuss one of the most rapidly evolving areas in melanoma care: immunotherapy treatment strategy. Look out for Episode 4, Melanoma Treatment Strategy: Expert Perspectives , dropping on Monday 1 June. [Listen](https://anchor.fm/s/a3c9a830/podcast/play/120656285/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-28%2F425042983-44100-2-8e6c72b3bdf4f.mp3) ## [Redefining Immunotherapy (Ep. 3): Immunotherapy Toxicity: Prevention, Early Recognition and Management to Optimise Outcome](https://podcasters.spotify.com/pod/show/melanoma-insights/episodes/Redefining-Immunotherapy-Ep--3-Immunotherapy-Toxicity-Prevention--Early-Recognition-and-Management-to-Optimise-Outcome-e3jj1v8) _2026-05-24 · Melanoma Institute Australia · Melanoma Insights for Professionals_ In our third episode of our special vodcast series, Redefining Immunotherapy: Lessons from Melanoma , our experts focus on one of the most important challenges in modern cancer care: immunotherapy toxicity. From subtle early warning signs to life-threatening immune-related adverse events, this episode explores how clinicians can better predict, recognise and manage toxicity while still maximising… [Listen](https://anchor.fm/s/a3c9a830/podcast/play/120210856/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-19%2F424449812-44100-2-6c02b97de90ec.mp3) ## [Redefining Immunotherapy (Ep. 2): Predict, Treat, Monitor: The Quest for Smarter Immunotherapy Decisions](https://podcasters.spotify.com/pod/show/melanoma-insights/episodes/Redefining-Immunotherapy-Ep--2-Predict--Treat--Monitor-The-Quest-for-Smarter-Immunotherapy-Decisions-e3jba17) _2026-05-17 · Melanoma Institute Australia · Melanoma Insights for Professionals_ In our second episode of our special vodcast series, Redefining Immunotherapy: Lessons from Melanoma , our experts tackle one of the biggest challenges in modern oncology: how do we make smarter immunotherapy decisions for individual patients? The panel explores the real-world factors that shape treatment selection in advanced melanoma; from tumour burden, brain and liver metastases, and BRAF… [Listen](https://anchor.fm/s/a3c9a830/podcast/play/119956967/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-14%2F424112386-44100-2-b97d58f6226b1.mp3) ## [Redefining Immunotherapy (Ep. 1): Beyond the Tumour: Rethinking Cancer in the Immunotherapy Era](https://podcasters.spotify.com/pod/show/melanoma-insights/episodes/Redefining-Immunotherapy-Ep--1-Beyond-the-Tumour-Rethinking-Cancer-in-the-Immunotherapy-Era-e3j472q) _2026-05-11 · Melanoma Institute Australia · Melanoma Insights for Professionals_ In this opening episode of our special vodcast series “Redefining Immunotherapy: Lessons from Melanoma”, our world-leading Medical Oncologists set the stage for a compelling five-part series exploring how immunotherapy is reshaping cancer care. Led by Prof Georgina Long AO, this engaging discussion unpacks how tumours evade the immune system, how checkpoint inhibitors work and why responses can be… [Listen](https://anchor.fm/s/a3c9a830/podcast/play/119724570/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-9%2F423798621-44100-2-ae1ed2864aa62.mp3) ## [Oncology Nursing Update: Nonmelanoma Skin Cancers — An Interview with Dr Nikhil Khushalani](https://dermatologic.researchtopractice.com/episode/6121-onu2026-nonmelanomaskin) _2026-05-07 · Dermatologic Oncology Update_ Dr Nikhil I Khushalani from the Moffitt Cancer Center in Tampa, Florida, discusses available and novel treatment strategies for nonmelanoma skin cancers. NCPD information and select publications here . [Listen](https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/5ae06408-53c2-4f4b-b4fc-0e2ad29496b4.mp3) ## [Nonmelanoma Skin Cancers — A Roundtable Discussion on the Multidisciplinary Management of Cutaneous Squamous Cell and Basal Cell Carcinomas](https://dermatologic.researchtopractice.com/episode/5875-nonmelanomaskinthinktank2025) _2026-04-02 · Dermatologic Oncology Update_ Dr Nikhil I Khushalani from Moffitt Cancer Center in Tampa, Florida, Dr Soo J Park from the UC San Diego Moores Cancer Center in California, Dr Vishal Anil Patel from the GW Cancer Center in Washington, DC, and Dr Evan Wuthrick, also from Moffitt Cancer Center, discusses recent updates on available and novel treatment strategies for nonmelanoma skin cancers. CME information and select publications… [Listen](https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/5158ab20-a115-474d-b830-acfccc2602e2.mp3) ## [100,000 Bonus Points Await You (Sponsored)](https://crawlproof.com/a/JStgx4tJJDZD) _2026-04-02 · **Sponsored**_ Earn 100,000 bonus points after spending $5,000 in the first 3 months. ## [After the diagnosis: Getting follow-up care right in melanoma](https://podcasters.spotify.com/pod/show/melanoma-insights/episodes/After-the-diagnosis-Getting-follow-up-care-right-in-melanoma-e3bmpu8) _2025-12-02 · Melanoma Institute Australia · Melanoma Insights for Professionals_ As patients transition from treatment to routine monitoring, clinicians play a crucial part in detecting recurrence early, supporting wellbeing, and guiding patients through survivorship. In the latest episode of our podcast Melanoma Insights for Professionals, we explore the essential role of follow-up care in melanoma management. Our multidisciplinary experts provide an engaging and practical… [Listen](https://anchor.fm/s/a3c9a830/podcast/play/111945096/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-11-1%2F9b5622bd-8f62-3e4c-ead8-24f5b7a1e137.mp3) ## [Overdiagnosis or early detection? The controversy of melanoma in situ](https://podcasters.spotify.com/pod/show/melanoma-insights/episodes/Overdiagnosis-or-early-detection--The-controversy-of-melanoma-in-situ-e39s832) _2025-10-21 · Melanoma Institute Australia · Melanoma Insights for Professionals_ As melanoma in situ (MIS) diagnoses rise, concerns about overdiagnosis are growing — with real implications for patients, clinicians and the health system. In this episode of our podcast Melanoma Insights for Professionals, experts from dermatology, pathology, psychology and research come together to explore the drivers of overdiagnosis, the psychological impact of an MIS label, and the role of… [Listen](https://anchor.fm/s/a3c9a830/podcast/play/110026274/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-9-21%2F5e25a369-54ae-11db-c556-ffe37aea24fa.mp3) ## [Utilising melanoma risk prediction tools for newly diagnosed patients](https://podcasters.spotify.com/pod/show/melanoma-insights/episodes/Utilising-melanoma-risk-prediction-tools-for-newly-diagnosed-patients-e36sj5n) _2025-08-15 · Melanoma Institute Australia · Melanoma Insights for Professionals_ In this episode, we explore how melanoma risk prediction tools are transforming clinical decision-making for newly diagnosed patients. These tools, developed by Melanoma Institute Australia and freely available at melanomarisk.org.au , help clinicians tailor care and improve outcomes. Our multidisciplinary experts provide practical guidance on using tools to predict sentinel node metastasis,… [Listen](https://anchor.fm/s/a3c9a830/podcast/play/106891895/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-7-15%2Fb6dc36dc-b80c-b656-871a-8444550fce94.mp3) ## [Soft Tissue Sarcoma and Other Connective Tissue Neoplasms — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting](https://dermatologic.researchtopractice.com/episode/5500-asco2025-sts) _2025-07-25 · Dermatologic Oncology Update_ Dr Rashmi Chugh from Rogel Comprehensive Cancer Center in Ann Arbor, Michigan, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize major clinical findings presented at the 2025 ASCO Annual Meeting for patients with soft tissue sarcoma and other connective tissue neoplasms. CME information and select publications here . [Listen](https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/2200af98-8152-4274-ac45-0320dd113fe2.mp3) ## [Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit](https://dermatologic.researchtopractice.com/episode/5353-gmo25-sarcoma) _2025-04-14 · Dermatologic Oncology Update_ Clinical investigators discuss available data guiding the management of sarcoma and other connective tissue neoplasms. CME information and select publications here . [Listen](https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/1be047a9-7753-4ff9-8690-d564d2b0ae4c/GMO25-Sarcoma.mp3) ## [Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel](https://dermatologic.researchtopractice.com/episode/5268-oncologytodaynf24) _2025-03-28 · Dermatologic Oncology Update_ Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1. CME information and select publications here . [Listen](https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/786781f9-20f5-4555-89df-f073b009fbaa/OncologyTodayNF24.mp3) ## [Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor](https://dermatologic.researchtopractice.com/episode/oncology-today-with-dr-neil-love-optimizing-the-management-of-tenosynovial-giant-cell-tumor) _2024-11-21 · Dermatologic Oncology Update_ Dr Emanuela Palmerini from the IRCCS Istituto Ortopedico Rizzoli in Bologna, Italy, discusses the current and future clinical treatment of tenosynovial giant cell tumor. [Listen](https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/1b405a47-e86c-414a-8aae-100961fe2a84/oncologytodaytgct24.mp3) ## [Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma](https://dermatologic.researchtopractice.com/episode/oncology-today-with-dr-neil-love-optimizing-the-management-of-dedifferentiated-liposarcoma) _2024-09-10 · Dermatologic Oncology Update_ Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas. [Listen](https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/ed655dd6-b6dd-43e9-9079-4137ade3045b/oncologytodayliposarcoma24.mp3)